Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 23 Jan 2024

Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma

in Hematologic Malignancies

Mizuki Tagami
Hiroaki Kasashima
Anna Kakehashi
Atsuko Yoshikawa
Mizuho Nishio
Norihiko Misawa
Atsushi Sakai
Hideki Wanibuchi
Masakazu Yashiro
Atsushi Azumi

Frontiers in Oncology

doi 10.3389/fonc.2024.1277749

2,457 views
6 citations

Original Research

Published on 19 Jan 2024

Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers

in Hematologic Malignancies

Yu Chang
Shiyong Li
Zhiming Li
Xinhua Wang
Fangyuan Chang
Shuaipeng Geng
Dandan Zhu
Guolin Zhong
Wei Wu
Yinyin Chang

Frontiers in Oncology

doi 10.3389/fonc.2024.1341997

5,119 views
6 citations

Case Report

Published on 19 Jan 2024

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

in Hematologic Malignancies

Roshan Asrani
Turgot Bora Cengiz
Bruce E. Petersen
Theodora Anagnostou
Joshua D. Brody

Frontiers in Oncology

doi 10.3389/fonc.2023.1254256

2,760 views

Original Research

Published on 17 Jan 2024

On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost

in Hematologic Malignancies

Li-qiong Hou
Jun-Ru Liu
Jing-Li Gu
Mei-Lan Chen
Li-Fen Kuang
Bei-Hui Huang
Wai-yi Zou
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1306367

2,604 views
1 citation

Original Research

Published on 15 Jan 2024

Prognostic significance of Wilms’ tumor gene 1 expression in children with B-cell precursor acute lymphoblastic leukemia

in Hematologic Malignancies

Yu-juan Xue
Yu Wang
Le-ping Zhang
Ai-dong Lu
Yue-ping Jia
Ying-xi Zuo
Hui-min Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1297870

2,354 views
1 citation

Review

Published on 12 Jan 2024

Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination

in Hematologic Malignancies

Magda Zanelli
Alessandra Bisagni
Francesca Sanguedolce
Giuseppe Broggi
Valentina Fragliasso
Maurizio Zizzo
Andrea Palicelli
Giovanni Martino
Camilla Cresta
Cecilia Caprera

Frontiers in Oncology

doi 10.3389/fonc.2023.1329298

7,002 views
8 citations

Original Research

Published on 11 Jan 2024

Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering

in Hematologic Malignancies

Chiyi Zhang
Ruiting Wen
Guocai Wu
Guangru Li
Xiaoqing Wu
Yunmiao Guo
Zhigang Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1301236

4,531 views
5 citations

Case Report

Published on 09 Jan 2024

Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report

in Hematologic Malignancies

Silvio Ligia
Emilia Scalzulli
Ida Carmosino
Giovanna Palumbo
Maria Chiara Molinari
Rebecca Poggiali
Alessandro Costa
Maria Laura Bisegna
Maurizio Martelli
Massimo Breccia

Frontiers in Oncology

doi 10.3389/fonc.2023.1338417

3,413 views
1 citation

Review

Published on 08 Jan 2024

Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules

in Hematologic Malignancies

Simona Bernardi
Olga Mulas
Silvia Mutti
Alessandro Costa
Domenico Russo
Giorgio La Nasa

Frontiers in Oncology

doi 10.3389/fonc.2023.1239042

3,759 views
10 citations

Original Research

Published on 05 Jan 2024

Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions

in Hematologic Malignancies

Rubí Romo-Rodríguez
Gabriela Zamora-Herrera
Jebea A. López-Blanco
Lucero López-García
Arely Rosas-Cruz
Laura Alfaro-Hernández
César Omar Trejo-Pichardo
Dulce Rosario Alberto-Aguilar
Diana Casique-Aguirre
Armando Vilchis-Ordoñez

Frontiers in Oncology

doi 10.3389/fonc.2023.1304662

10,993 views
4 citations

Original Research

Published on 04 Jan 2024

Simulating neuronal development: exploring potential mechanisms for central nervous system metastasis in acute lymphoblastic leukemia

in Hematologic Malignancies

Ziping Li
Zhi Guo
Haitao Xiao
Xuexing Chen
Wei Liu
Hao Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1331802

3,170 views
3 citations

Brief Research Report

Published on 04 Jan 2024

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia

in Hematologic Malignancies

Zhuanghui Hao
Juan Li
Feng Gao
Weixiao Ren
Xiaomei Lu
Jinyi Feng
Chen Zhang
Sicheng Bian
Juan Xie
Ming Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.1265022

3,838 views

Case Report

Published on 03 Jan 2024

Case report: EBV-positive epithelioid follicular dendritic cell sarcoma with CD30 expression: a highly challenging diagnosis

in Hematologic Malignancies

Ying Chen
Xin He
Xingyan Zhu
Yujuan Xu
Deyu Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1321565

2,477 views
2 citations

Review

Published on 20 Dec 2023

Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials

in Hematologic Malignancies

Fateen Ata
Maria Benkhadra
Rola Ghasoub
Liam J. Fernyhough
Nabil E. Omar
Abdulqadir J. Nashwan
Mahmood B. Aldapt
Kamran Mushtaq
Nancy A. Kassem
Mohamed A. Yassin

Frontiers in Oncology

doi 10.3389/fonc.2023.1285346

4,680 views
7 citations

Editorial

Published on 19 Dec 2023

Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation

in Hematologic Malignancies

Nelson Hamerschlak
David Gómez-Almaguer
Donal P. McLornan

Frontiers in Oncology

doi 10.3389/fonc.2023.1321334

2,002 views
1 citation

Review

Published on 15 Dec 2023

Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential

in Hematologic Malignancies

Anna Maria Cacic
Felicitas Isabel Schulz
Ulrich Germing
Sascha Dietrich
Norbert Gattermann

Frontiers in Oncology

doi 10.3389/fonc.2023.1303785

9,394 views
5 citations

Systematic Review

Published on 14 Dec 2023

Prevalence and prognostic value of baseline sarcopenia in hematologic malignancies: a systematic review

in Hematologic Malignancies

Xiaofeng Zeng
Liying Zhang
Yu Zhang
Shuli Jia
Taiping Lin
Xuman Zhao
Xiaoli Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1308544

3,664 views
5 citations

Editorial

Published on 13 Dec 2023

Editorial: Challenges in peripheral T-cell lymphomas: from biological advances to clinical applicability

in Hematologic Malignancies

Luís Alberto de Pádua Covas Lage
Juliana Pereira
Ryan A. Wilcox

Frontiers in Oncology

doi 10.3389/fonc.2023.1325170

1,293 views
1 citation

Case Report

Published on 13 Dec 2023

Co-existence of KMT2A::SEPTIN6 fusion and DIS3 variant in a pediatric case with acute myeloid leukemia: a case report and literature review

in Hematologic Malignancies

Liang Wang
Fangzhou Qiu
Yongming Shen
Sen Chen
Ping Si

Frontiers in Oncology

doi 10.3389/fonc.2023.1308786

2,656 views
1 citation

Mini Review

Published on 11 Dec 2023

The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma

in Hematologic Malignancies

Patrick Nylund
Berta Garrido-Zabala
Antonia Kalushkova
Helena Jernberg Wiklund

Frontiers in Oncology

doi 10.3389/fonc.2023.1303677

3,428 views
3 citations

Original Research

Published on 07 Dec 2023

Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study

in Hematologic Malignancies

Anna Cardellino
Julia R. Correll
Mona Martin
Boris Gorsh
Sandhya Sapra
Rakesh Popat

Frontiers in Oncology

doi 10.3389/fonc.2023.1274659

3,600 views
5 citations

Review

Published on 06 Dec 2023

Deep learning enhances acute lymphoblastic leukemia diagnosis and classification using bone marrow images

in Hematologic Malignancies

Basel Elsayed
Mohamed Elhadary
Raghad Mohamed Elshoeibi
Amgad Mohamed Elshoeibi
Ahmed Badr
Omar Metwally
Raghad Alaa ElSherif
Mohamed Elsayed Salem
Fatima Khadadah
Awni Alshurafa

Frontiers in Oncology

doi 10.3389/fonc.2023.1330977

8,961 views
30 citations

Brief Research Report

Published on 06 Dec 2023

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma

in Hematologic Malignancies

Angélique Bruyer
Laure Dutrieux
Hugues de Boussac
Thibaut Martin
Djamila Chemlal
Nicolas Robert
Guilhem Requirand
Guillaume Cartron
Laure Vincent
Charles Herbaux

Frontiers in Oncology

doi 10.3389/fonc.2023.1271847

3,808 views
8 citations

Review

Published on 06 Dec 2023

Molecular mechanisms of ferroptosis and its roles in leukemia

in Hematologic Malignancies

Zhe Chen
Suying Zheng
Jiongping Han
Leihua Fu
Jiaping Fu
Zhijian Zhang
Pan Hong
Weiying Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1308869

5,171 views
10 citations

2,053 articles

articles

Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma

Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost

Prognostic significance of Wilms’ tumor gene 1 expression in children with B-cell precursor acute lymphoblastic leukemia

Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination

Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering

Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report

Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules

Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions

Simulating neuronal development: exploring potential mechanisms for central nervous system metastasis in acute lymphoblastic leukemia

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia

Case report: EBV-positive epithelioid follicular dendritic cell sarcoma with CD30 expression: a highly challenging diagnosis

Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials

Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation

Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential

Prevalence and prognostic value of baseline sarcopenia in hematologic malignancies: a systematic review

Editorial: Challenges in peripheral T-cell lymphomas: from biological advances to clinical applicability

Co-existence of KMT2A::SEPTIN6 fusion and DIS3 variant in a pediatric case with acute myeloid leukemia: a case report and literature review

The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma

Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study

Deep learning enhances acute lymphoblastic leukemia diagnosis and classification using bone marrow images

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma

Molecular mechanisms of ferroptosis and its roles in leukemia